Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif-containing protein 71 (TRIM71) is an E3 ubiquitin-protein ligase and RNA-binding protein characterized by an N-terminal RING domain (conferring E3 ligase activity) and a C-terminal NHL domain (mediating RNA binding). TRIM71 is a key post-transcriptional regulator of gene expression in embryonic stem cells and neural progenitors, functioning mainly by binding to and repressing transcripts with hairpin motifs in their 3′UTRs, either leading to target degradation or inhibiting translation. It also interacts with the microRNA (miRNA) machinery, contributing independently and synergistically with miRNAs to repress target gene expression like CDKN1A/p21, thereby promoting self-renewal, proliferation, and maintenance of undifferentiated cell states. Mutations in TRIM71 are causative of congenital hydrocephalus and may have broader implications in stem cell biology and oncogenesis.
Facilitation of ubiquitin-mediated protein degradation (as E3 ligase); Post-transcriptional repression of mRNAs (including miRNA-dependent mechanisms); RNA hairpin recognition and direct silencing of mRNA targets
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing protein 71 (TRIM71).